A CEO’s Guide To Sustaining Change Over Time

Despite the high stakes, more than half of boards and CEOs are not confident their succession planning is adequate.

How pharma and biotech leaders can navigate today’s challenging landscape—focusing on revamped approaches in business operations, talent strategy and development, and more to meet the evolving demands.

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

As basic analytical work becomes most cost efficient and handled internally or by AI, consulting firms must reinvent themselves around senior judgment, integration of complex systems, and making decisions that hold up under real constraints instead of relying on the old pyramid model.

‍

A strategy usually doesn’t fail because the plan is bad, it fails because the organization hasn’t built clear decision rights, operating rhythms, and follow-through systems that make accountability real.

La revista de El Mundo reconoce a las compañías que han demostrado un compromiso excepcional en el bienestar y desarrollo de todos sus profesionales. BTS ha sido galardonado con el puesto 17º en la lista.

‍